Titre : Franchises et coassurance

Franchises et coassurance : Questions médicales fréquentes

Termes MeSH sélectionnés :

Reference Standards
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Franchises et coassurance : Questions médicales les plus fréquentes", "headline": "Franchises et coassurance : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Franchises et coassurance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-08", "dateModified": "2025-04-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Franchises et coassurance" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Participation aux coûts", "url": "https://questionsmedicales.fr/mesh/D017047", "about": { "@type": "MedicalCondition", "name": "Participation aux coûts", "code": { "@type": "MedicalCode", "code": "D017047", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N03.219.521.576.090" } } }, "about": { "@type": "MedicalCondition", "name": "Franchises et coassurance", "alternateName": "Deductibles and Coinsurance", "code": { "@type": "MedicalCode", "code": "D003669", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "J Frank Wharam", "url": "https://questionsmedicales.fr/author/J%20Frank%20Wharam", "affiliation": { "@type": "Organization", "name": "Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA." } }, { "@type": "Person", "name": "Alisa B Busch", "url": "https://questionsmedicales.fr/author/Alisa%20B%20Busch", "affiliation": { "@type": "Organization", "name": "Department of Health Care Policy, Harvard Medical School." } }, { "@type": "Person", "name": "Fang Zhang", "url": "https://questionsmedicales.fr/author/Fang%20Zhang", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Dennis Ross-Degnan", "url": "https://questionsmedicales.fr/author/Dennis%20Ross-Degnan", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Mark K Meiselbach", "url": "https://questionsmedicales.fr/author/Mark%20K%20Meiselbach", "affiliation": { "@type": "Organization", "name": "Health Policy and Management, Johns Hopkins University, Baltimore, Maryland, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard.", "datePublished": "2022-08-29", "url": "https://questionsmedicales.fr/article/36038643", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00261-022-03647-6" } }, { "@type": "ScholarlyArticle", "name": "The diagnostic value of dual-layer CT in the assessment of lymph nodes in lymphoma patients with PET/CT as a reference standard.", "datePublished": "2023-10-26", "url": "https://questionsmedicales.fr/article/37884597", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-45198-w" } }, { "@type": "ScholarlyArticle", "name": "Towards standardization of measuring anxiety and depression: Differential item functioning for language and Dutch reference values of PROMIS item banks.", "datePublished": "2022-08-23", "url": "https://questionsmedicales.fr/article/35998333", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0273287" } }, { "@type": "ScholarlyArticle", "name": "Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI.", "datePublished": "2023-01-03", "url": "https://questionsmedicales.fr/article/36594836", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1148/radiol.220984" } }, { "@type": "ScholarlyArticle", "name": "Comparing diagnostic performance of Cantonese-Chinese version of Rome IV criteria and a short Reference Standard for functional dyspepsia in China.", "datePublished": "2022-10-12", "url": "https://questionsmedicales.fr/article/36224557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12876-022-02520-6" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Organisations et économie des soins de santé", "item": "https://questionsmedicales.fr/mesh/D004472" }, { "@type": "ListItem", "position": 3, "name": "Économie", "item": "https://questionsmedicales.fr/mesh/D004467" }, { "@type": "ListItem", "position": 4, "name": "Financement organisé", "item": "https://questionsmedicales.fr/mesh/D005381" }, { "@type": "ListItem", "position": 5, "name": "Assurance", "item": "https://questionsmedicales.fr/mesh/D007341" }, { "@type": "ListItem", "position": 6, "name": "Participation aux coûts", "item": "https://questionsmedicales.fr/mesh/D017047" }, { "@type": "ListItem", "position": 7, "name": "Franchises et coassurance", "item": "https://questionsmedicales.fr/mesh/D003669" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Franchises et coassurance - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Franchises et coassurance", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Franchises et coassurance", "description": "Qu'est-ce qu'une franchise en assurance santé ?\nComment fonctionne la coassurance ?\nQuelle est la différence entre franchise et coassurance ?\nComment sont calculées les franchises ?\nLes franchises sont-elles remboursables ?", "url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Reference+Standards&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Franchises et coassurance", "description": "Quels sont les impacts d'une franchise élevée ?\nComment la coassurance affecte-t-elle les patients ?\nLes patients ressentent-ils du stress à cause des franchises ?\nLes franchises influencent-elles la santé des patients ?\nY a-t-il des symptômes financiers liés à la coassurance ?", "url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Reference+Standards&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Franchises et coassurance", "description": "Comment éviter des frais élevés de franchise ?\nLes bilans de santé sont-ils couverts sans franchise ?\nComment éduquer les patients sur les franchises ?\nLes programmes de prévention réduisent-ils les coûts ?\nComment les patients peuvent-ils planifier leurs soins ?", "url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Reference+Standards&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Franchises et coassurance", "description": "Comment choisir un plan avec franchise ?\nLes traitements préventifs sont-ils couverts ?\nComment réduire les coûts de coassurance ?\nLes médicaments sont-ils soumis à la franchise ?\nLes soins d'urgence sont-ils affectés par la coassurance ?", "url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Reference+Standards&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Franchises et coassurance", "description": "Quelles complications peuvent survenir avec des franchises élevées ?\nLa coassurance peut-elle entraîner des complications financières ?\nLes patients évitent-ils des soins à cause des coûts ?\nComment les complications de santé affectent-elles les coûts ?\nLes complications dues à la coassurance sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Reference+Standards&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Franchises et coassurance", "description": "Quels facteurs augmentent les coûts de franchise ?\nComment le choix de l'assurance affecte-t-il les coûts ?\nLes maladies chroniques augmentent-elles les frais ?\nLes jeunes adultes ont-ils des franchises plus basses ?\nLes habitudes de santé influencent-elles les coûts ?", "url": "https://questionsmedicales.fr/mesh/D003669?mesh_terms=Reference+Standards&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Qu'est-ce qu'une franchise en assurance santé ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "C'est le montant que le patient doit payer avant que l'assurance ne couvre les frais." } }, { "@type": "Question", "name": "Comment fonctionne la coassurance ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "C'est le pourcentage des frais médicaux que le patient doit payer après la franchise." } }, { "@type": "Question", "name": "Quelle est la différence entre franchise et coassurance ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "La franchise est un montant fixe, tandis que la coassurance est un pourcentage des frais." } }, { "@type": "Question", "name": "Comment sont calculées les franchises ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont généralement fixées par le contrat d'assurance et varient selon les plans." } }, { "@type": "Question", "name": "Les franchises sont-elles remboursables ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, les montants de franchise ne sont pas remboursés par l'assurance." } }, { "@type": "Question", "name": "Quels sont les impacts d'une franchise élevée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une franchise élevée peut dissuader les patients de consulter des soins médicaux." } }, { "@type": "Question", "name": "Comment la coassurance affecte-t-elle les patients ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des coûts supplémentaires pour les patients lors de soins médicaux." } }, { "@type": "Question", "name": "Les patients ressentent-ils du stress à cause des franchises ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les coûts imprévus peuvent causer de l'anxiété financière chez les patients." } }, { "@type": "Question", "name": "Les franchises influencent-elles la santé des patients ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent limiter l'accès aux soins, affectant ainsi la santé globale des patients." } }, { "@type": "Question", "name": "Y a-t-il des symptômes financiers liés à la coassurance ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des frais médicaux imprévus peuvent entraîner des difficultés financières." } }, { "@type": "Question", "name": "Comment éviter des frais élevés de franchise ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Choisissez un plan avec une franchise adaptée à vos besoins médicaux prévisibles." } }, { "@type": "Question", "name": "Les bilans de santé sont-ils couverts sans franchise ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Souvent, les bilans de santé préventifs sont couverts sans frais de franchise." } }, { "@type": "Question", "name": "Comment éduquer les patients sur les franchises ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Fournissez des informations claires sur les coûts et les options d'assurance disponibles." } }, { "@type": "Question", "name": "Les programmes de prévention réduisent-ils les coûts ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire les coûts à long terme en évitant des soins coûteux." } }, { "@type": "Question", "name": "Comment les patients peuvent-ils planifier leurs soins ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Ils doivent évaluer leurs besoins et choisir des soins en fonction de leur plan d'assurance." } }, { "@type": "Question", "name": "Comment choisir un plan avec franchise ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Évaluez vos besoins médicaux et comparez les coûts des franchises et coassurances." } }, { "@type": "Question", "name": "Les traitements préventifs sont-ils couverts ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Souvent, les traitements préventifs sont couverts sans franchise, selon le plan." } }, { "@type": "Question", "name": "Comment réduire les coûts de coassurance ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Choisissez des soins dans le réseau de votre assurance pour réduire les frais." } }, { "@type": "Question", "name": "Les médicaments sont-ils soumis à la franchise ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent être soumis à la franchise selon le plan d'assurance." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils affectés par la coassurance ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les soins d'urgence peuvent entraîner des frais de coassurance après la franchise." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des franchises élevées ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les patients peuvent retarder des soins nécessaires, entraînant des complications de santé." } }, { "@type": "Question", "name": "La coassurance peut-elle entraîner des complications financières ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des frais imprévus peuvent causer des dettes médicales importantes." } }, { "@type": "Question", "name": "Les patients évitent-ils des soins à cause des coûts ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les coûts élevés peuvent dissuader les patients de rechercher des soins médicaux." } }, { "@type": "Question", "name": "Comment les complications de santé affectent-elles les coûts ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent entraîner des frais médicaux supplémentaires et imprévus." } }, { "@type": "Question", "name": "Les complications dues à la coassurance sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreux patients rencontrent des difficultés à payer leurs frais médicaux." } }, { "@type": "Question", "name": "Quels facteurs augmentent les coûts de franchise ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, les antécédents médicaux et le type de soins peuvent influencer les coûts." } }, { "@type": "Question", "name": "Comment le choix de l'assurance affecte-t-il les coûts ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Différents plans d'assurance ont des franchises et coassurances variées, influençant les coûts." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles les frais ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients avec des maladies chroniques peuvent faire face à des frais plus élevés." } }, { "@type": "Question", "name": "Les jeunes adultes ont-ils des franchises plus basses ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Souvent, les jeunes adultes choisissent des plans avec des franchises plus basses." } }, { "@type": "Question", "name": "Les habitudes de santé influencent-elles les coûts ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de santé positives peuvent réduire les frais médicaux à long terme." } } ] } ] }

Sources (10000 au total)

Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard.

To compare the diagnostic performance of T1 mapping and MR elastography (MRE) for staging of hepatic fibrosis and grading inflammation with histopathology as standard of reference.... 68 patients with various liver diseases undergoing liver biopsy for suspected fibrosis or with an established diagnosis of cirrhosis prospectively underwent look-locker inversion recovery T1 mapping a... Histopathological analysis diagnosed 9 patients with F0 (13.2%), 21 with F1 (30.9%), 11 with F2 (16.2%), 10 with F3 (14.7%), and 17 with F4 (25.0%). Both T1 mapping and MRE showed significantly higher... T1 mapping is able to diagnose hepatic fibrosis, however, with a tendency toward lower diagnostic performance compared to MRE and thus may be used as an alternative to MRE for diagnosing hepatic fibro...

The diagnostic value of dual-layer CT in the assessment of lymph nodes in lymphoma patients with PET/CT as a reference standard.

This study aimed to evaluate the diagnostic performances of dual-layer CT (DLCT) for the identification of positive lymph nodes (LNs) in patients with lymphoma and retrospectively included 1165 LNs ob...

Towards standardization of measuring anxiety and depression: Differential item functioning for language and Dutch reference values of PROMIS item banks.

The outcomes anxiety and depression are measured frequently by healthcare providers to assess the impact of a disease, but with numerous instruments. PROMIS item banks provide an opportunity for stand... PROMIS Anxiety and Depression item banks were completed by 1002 representative Dutch persons. To evaluate cross-cultural validity, data from US participants in PROMIS wave 1 were used and differential... In both item banks, two items had DIF but with minimal impact on population level T-scores for full item banks and short forms. The Dutch general population had a T-score of 49.9 for anxiety and 49.6 ... The limited number of items with DIF and its minimal impact, enables the use of standard (US) item parameters and comparisons of scores between Dutch and US populations. The Dutch reference values pro...

Comparing diagnostic performance of Cantonese-Chinese version of Rome IV criteria and a short Reference Standard for functional dyspepsia in China.

Functional dyspepsia (FD) is diagnosed based on self-reported symptoms and negative upper gastrointestinal endoscopic findings. The Rome criteria were not adopted as a diagnostic instrument in clinica... A total of 220 dyspeptic patients sampled consecutively from a tertiary hospital and the community completed the Rome IV diagnostic questionnaire, which was translated into Cantonese-Chinese, and the ... Among the participants, 160 (72.7%) fulfilled the Reference Standard with negative upper gastrointestinal endoscopic results. The Reference Standard identified patients with Rome IV-defined FD with 91... The Reference Standard can rule out patients without Rome IV-defined FD. It may be used as an initial screening tool for FD in settings where the use of the Rome IV criteria is impractical. It may als...

Simultaneous alleviation of verification and reference standard biases in a community-based tuberculosis screening study using Bayesian latent class analysis.

Estimation of prevalence and diagnostic test accuracy in tuberculosis (TB) prevalence surveys suffer from reference standard and verification biases. The former is attributed to the imperfect referenc... We performed a secondary analysis of 9869 participants aged ≥15 years from a community-based multimorbidity screening study in a rural district of KwaZulu-Natal, South Africa (Vukuzazi study). Partici... Based on simulation, Bayesian LCA with simultaneous imputation of the missing bacteriological test results under the assumption that the missing data are MAR and MNAR alleviate the reference standard ... The findings demonstrate the efficacy of these advanced techniques in alleviating the reference standard and verification biases, enhancing the robustness of community-based screening programs. Imputi...

Agreement of LC-MS assays for IGF-1 traceable to NIST and WHO standards permits harmonization of reference intervals between laboratories.

In this study, we aimed to determine the feasibility of transferring IGF-1 reference intervals between two liquid chromatography-mass spectrometry assays with distinct assay formats and calibration tr... To adopt a reference interval (RI) for our new assay we have conducted RI transference and verification studies according to the CLSI EP28-A3c and EP9c guidelines. Specifically, the analytical agreeme... Our study showed a strong correlation (R... Taken together, this study provides data to suggest excellent agreement between assays traceable to distinct reference standards for IGF-1....

Zero Echo Time vs. T1-Weighted MRI for Assessment of Cortical and Medullary Bone Morphology Abnormalities Using CT as the Reference Standard.

Conventional MR pulse sequences result in poor signal from low T2 cortical bone because the minimum achievable echo time is limited. A sequence resulting in improved bone contrast is desirable.... To evaluate the image quality and diagnostic performance of grayscale inversion zero echo time imaging (GI-ZTE) and grayscale inversion T1-weighted imaging (GI-T1WI) compared with computed tomography ... Prospective.... A total of 50 patients with musculoskeletal tumors or tumor-like diseases of the lower extremities having MRI and CT studies.... GI-T1WI and GI-ZTE sequences at 1.5 T.... Assessed cortical and medullary bone morphology abnormalities using CT as the reference standard. Three radiologists scored the images quality and recorded nine metrics to assess the diagnostic perfor... Differences in image quality were calculated using the Wilcoxon signed-rank test. The intraclass correlation coefficient (ICC) was used to analyze the agreement of quantitative lesion parameters betwe... Image quality score was significantly higher for CT images than GI-TIWI images. Except for radiologist 3 [4(0) vs 4 (1)], there was no significant difference in scores between CT and GI-ZTE [radiologi... GI-ZTE images had superior intermodality agreement with CT images and allowed visualization of more cortical bone detail than GI-T1WI images.... 1.... Stage 2....

Diagnostic accuracy for self-reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine-dependent intervention trial population.

Treatment of methamphetamine dependence requires monitoring of recent use or abstinence. Self-report is commonly used for routine monitoring, but the accuracy of self-report is not established. For th... This study was a secondary (subgroup) analysis from a randomized controlled pharmacotherapy trial. Three Australian outpatient addiction services took part. Particpants were 139 people dependent on me... Weekly oral fluid samples over 12 weeks to determine methamphetamine (and amphetamine) concentrations were used as the reference standard. Self-report of any methamphetamine use in the previous 7 days... Sensitivity was 96.4% [95% confidence interval (CI) = 95-97.5], specificity was 63.7% (95% CI = 57.3-69.8) and positive predictive value (PPV) was 90.8% (95% CI = 88.8-92.6). The unadjusted NPV was 82... Self-report of no recent methamphetamine use appears to be sufficiently accurate to be clinically useful at the expected prevalence rates of methamphetamine use in clinical treatment settings. If gene...

Sensitivity and specificity of OraQuick® HIV self-test compared to a 4th generation laboratory reference standard algorithm in urban and rural Zambia.

HIV self-testing (HIVST) has the potential to increase coverage of HIV testing, but concerns exist about intended users' ability to correctly perform and interpret tests, especially in poor communitie... Participants were recruited from randomly selected rural and urban households and one urban health facility between May 2016 and June 2017. Participants received a brief demonstration of the self-test... Initial piloting showed that written instructions alone were inadequate, and a demonstration of self-test use was required. Of 2,566 self-test users, 2,557 (99.6%) were able to interpret their result.... Self-testers in Zambia who used OraQuick® HIV Self-Test achieved reasonable clinical performance compared to the national RDT algorithm. However, sensitivity of the self-test was reduced compared to a...